Larvol Delta - Taiho-Oncology-Taiho-Pharmaceutical-and-Araris-Biotech-AG-Advance-ADC-ARC02-into-Phase-1-Clinical-Development

ARC-02 - Otsuka

https://www.businesswire.com/news/home/20260427127507/en/Taiho-Oncology-Taiho-Pharmaceutical-and-Araris-Biotech-AG-Advance-ADC-ARC-02-into-Phase-1-Clinical-Development

Apr 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next